Clinical Trial

Impact of Insomnia Treatment on Brain Responses During Resting-state and Cognitive Tasks

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Individuals with chronic insomnia have persistent difficulty falling and staying asleep, as well as complaints of altered daytime functioning that may be associated with cognitive impairments. The neural processes underlying these daytime complaints may involve abnormal activation of brain regions and neural networks involved in working memory, memory encoding and emotions. The goal of this study is to assess whether a psychological treatment for insomnia will reverse these abnormalities in brain responses to cognitive tasks and at rest. A secondary objective of the study is to characterize impairments in attentional processing and assess if the impairments can be reversed by the psychological treatment. We hypothesized that the psychological treatment for insomnia will lead to a normalization of the brain responses to working memory, declarative memory encoding, insomnia-related stimuli, and the functional connectivity within the default-mode and limbic networks.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-07-17; most recent amendment 2026-03-16.
Status change: Recruiting → Active, Not Recruiting 2026-03-16
Trial Details
NCT Number NCT04024787
Lead Sponsor Concordia University, Montreal
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions Chronic Insomnia
Enrollment 120 participants
Start Date 2019-07-30
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-18